PTPN22 and neoplasm: Flow cytometry analysis of host lymph nodes and spleens determined that a population of transferred central memory phenotype Ptpn22–/– CD8+CD44hiCD62L+ T cells could be detected at the experimental endpoint (day 90 after tumor challenge and day 104 after ACT) (Figure 6, E and F).